+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe L-Carnosine Market 2020-2026

  • PDF Icon


  • August 2020
  • Region: Europe
  • Orion Market Research Private Limited
  • ID: 5148050
Europe L-Carnosine Market Size, Share & Trends Analysis Report by Application (Autism, Diabetes, Skin Support, Cardiovascular Support, Joint Support, and Others) and Forecast, 2020-2026.

Europe L-carnosine market is estimated to grow at a CAGR of around 4.3% during the forecast period. The market is driven by increasing diabetes, eye disorders (cataracts), and kidney-related disorders. There is a growing demand for L-carnosine for the prevention and treatment of complications associated with diabetes such as nerve damage, and eye disorders (cataracts). Therefore, the increasing prevalence of diabetes is one of the primary factors which is contributing to the growth of the market. According to IDF Europe, in 2018, more than 58 million diabetic people were living in Europe; this number is expected to reach 66.7 million by 2045. This trend suggests that the demand for L-carnosine in Europe will increase significantly in the near future.

Europe L-carnosine market is segmented on the basis of application and geography. Based on the application, the market is segmented into autism, diabetes support, skin support, CVD support, joint support, and others. Others segment include digestion support, Parkinson’s disease, and Alzheimer’s disease. In 2019, the skin support segment is projected to contribute a significant share to the global market.

Moreover, the report covers the country-level analysis of the Europe L-carnosine market. The economies covered in the report studied include UK, Germany, Italy, Spain, France, and the Rest of Europe. UK L-carnosine market is estimated to grow significantly during the forecast period. The growth is attributed to the increasing incidence and prevalence rate of chronic diseases, such as CVDs (cardiovascular diseases) and diabetes. The prevalence of diabetes has changed significantly in the UK. It has increased from a year on year growth of 2.9% to 7.6% among men between the period 1994-2016, and 1.9% to 2.6% among women in the same period.

L-carnosine market players are making efforts to develop L-carnosine products for various purposes such as managing aging and cardiovascular health & cellular protection. Bachem AG is a Switzerland-based company offering more than 5,500 different biologically active peptides, amino acid derivatives, and biochemicals through its online portal. It has a global reach with the subsidiaries in the US, UK, and Japan. Moreover, the company has distributors network in Austria, Belgium, Brazil, Canada, France, Germany, India, Italy, Luxembourg, the Netherlands, Spain, and Taiwan. The company offers L-carnosine in a pack size of 5 gm and 25 gm. The list price of 5 gm L-carnosine is194, and826 for 25 gm packs.

Research Methodology:

The market study of the Europe L-carnosine market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market
  • Authentic public databases
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog

The report is intended for the pharmaceutical companies, healthcare industry, research institutes, academic institutes, dietary supplement companies, investing companies, government organizations, regulatory bodies, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:
  • Europe L-carnosine Market Research and Analysis by Application

The Report Covers:
  • Comprehensive research methodology of the Europe L-carnosine market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Europe L-carnosine market.
  • Insights about market determinants which are stimulating the Europe L-carnosine market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Country
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Key Strategy Analysis
4. Market Determinants
4.1. Motivators
4.2. Restraints/Challenges
4.3. Opportunities
5. Market Segmentation
5.1. Europe L-carnosine Market by Application
5.1.1. Autism
5.1.2. Diabetes
5.1.3. Skin Support
5.1.4. Cardiovascular Support
5.1.5. Joint Support
5.1.6. Others
6. Regional Analysis
6.1. UK
6.2. Germany
6.3. France
6.4. Spain
6.5. Italy
6.6. Rest of Europe
7. Company Profiles
7.1. Bachem AG
7.2. Cambridge Bioscience Ltd.
7.3. Jarrow Formulas, Inc.
7.4. Kirkman Group, Inc.
7.5. Merck KGaA
7.6. NOW Foods, LLC
7.7. Quest Vitamins Ltd.
7.8. ZeinPharma Germany GmbH

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Bachem AG
  • Cambridge Bioscience Ltd.
  • Jarrow Formulas, Inc.
  • Kirkman Group, Inc.
  • Merck KGaA
  • NOW Foods, LLC
  • Quest Vitamins Ltd.
  • ZeinPharma Germany GmbH